Nitto Denko Corporation Informations sur les dividendes
Nitto Denko Corporation a un dividende annuel de 0.40 par action, avec un rendement de 0.00%. Le dividende est payé semestriellement et la dernière date d'ex-dividende était le Sep 29, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.40
Sep 29, 2025
Fréquence des paiements
Taux de distribution
Semestriellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Sep 29, 2025
$30.00
Sep 30, 2025
Nov 28, 2025
Mar 28, 2025
$28.00
Mar 31, 2025
Jun 23, 2025
Sep 27, 2024
$28.00
Sep 30, 2024
Nov 29, 2024
Mar 28, 2024
$26.00
Mar 31, 2024
Jun 24, 2024
Sep 28, 2023
$26.00
Sep 30, 2023
Nov 24, 2023
Mar 30, 2023
$24.00
Mar 31, 2023
Jun 26, 2023
Graphiques des dividendes
NDEKF Dividendes
NDEKF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Nitto Denko Corporation et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Nitto Denko Corporation ?
Quelle est la date ex-dividende pour NDEKF ?
À quelle fréquence Nitto Denko Corporation verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
$23.55
Prix d'ouverture
$23.55
Plage de la journée
$23.55 - $23.55
Plage de 52 semaines
$16.4 - $25.7
Volume
100
Volume moyen
57
BPA (TTM)
1.17
Rendement en dividend
--
Capitalisation boursière
$15.8B
Qu’est-ce que Nitto Denko Corp. ?
Nitto Denko Corp. engages in the manufacture and sale of adhesives, optical films, semiconductors, electronic devices, and consumer products. The company is headquartered in Osaka, Osaka-Fu and currently employs 25,769 full-time employees. The firm operates in three business segments. The Industrial Tapes segment is engaged in the manufacture and sale of basic functional materials such as bonding materials and protective materials, as well as automotive materials. The Optronics segment is engaged in the manufacture and sale of information functional materials, printed circuits and process materials. The Human Life Science segment is engaged in the manufacture and sale of nucleic acid contract manufacturing, nucleic acid synthesis materials, nucleic acid drug discovery, medical-related materials and other life sciences, membranes such as polymer separation membranes, and personal care materials such as functional films for hygiene materials. The firm is also engaged in the manufacture and sale of new businesses and other products.